July 10, 2026
A new study associated with Immorta Bio suggests that combining a senolytic vaccine with mesenchymal stem cells might create a synergistic impact. However, the findings rest on acute, artificially induced injury models rather than natural aging [1]. Clearing out senescent cells to help stem cells work Mesenchymal stem cell (MSC) therapies have largely underperformed in...